Monoclonal antibodies prepared to human myelin-associated glycoprotein were shown to react with a population of human peripheral blood mononuclear cells. The population is similar to the large granular lymphocytes or natural killer cells defined by antibody Leu 7 (also called HNK-1). The population also includes cells exhibiting the Leu 2 marker for suppressor/cytotoxic T cells. The results indicate a shared antigenicity between the nervous system and the immune system and may be relevant to the pathogenesis of demyelinating diseases.
Evidence has been accumulating for shared antigenic determinants between the nervous system and the immune system (1) (2) (3) (4) (5) . This crossreactivity may be involved in the etiopathology of such neurological diseases as multiple sclerosis (5) and myasthenia gravis (3, 4) . It recently has been demonstrated that Leu 7 (or HNK-1)-a mouse monoclonal antibody, raised to a human lymphoblastoma, that recognizes human natural killer cells-reacts with components of nervous tissue (6, 7) . The myelin-associated glycoprotein (MAG) was identified as a molecule in nervous tissue containing the epitope recognized by this monoclonal antibody (7, 8) . Furthermore, the epitope in MAG is in its carbohydrate moieties (9) and also is in other glycoconjugates of peripheral nerve (9, 10) .
In this paper, we describe the reaction of mouse monoclonal antibodies prepared to MAG (11) with a subpopulation of human peripheral blood mononuclear cells. Further experiments show that this population is similar to the large granular lymphocytes (LGL) recognized by Leu 7. The results indicate that MAG and a population of peripheral blood lymphocytes share a common antigenic determinant. This finding may have relevance in the pathogenesis of demyelinating diseases.
MATERIALS AND METHODS
Monoclonal Antibodies. Murine monoclonal antibodies to MAG were produced as described (11) . Briefly, P3X63-Ag8.653 myeloma cells were fused with spleen cells from a female NZB/N mouse immunized with purified human MAG isolated from the central nervous system. Hybrids and subsequent clones were screened for antibody production to MAG by using a solid-phase enzyme immunoassay system. The following monoclonal antibodies were used in this study: G7C8, E8B8, and C6D9 of the IgM subclass with K light chains, which react with determinants in the carbohydrate moieties of human MAG; F7F7, an IgG2b subclass antibody with K light chains, which also reacts with a carbohydrate determinant of human MAG; and B11F7 (IgG2b) and D7E10 (IgGl) with K light chains, which react with polypeptide determinants of human and rat MAG. The hybridomas were grown as ascites tumors in pristane-primed NIH/Swiss nude mice. Monoclonal antibodies were purified from ascites fluid by Sepharose-protein A affinity chromatography (12) for antibodies F7F7 and B11F7 and by euglobulin fractionation followed by Sephadex G-200 chromatography (13) for antibody G7C8. Hybridoma HNK-1 (14) was purchased from the American Type Culture Collection. The hybridoma was grown and the monoclonal antibody was purified as described above for G7C8.
Isolation of Mononuclear Blood Cells. Human peripheral blood was obtained from normal volunteers as approved by the Clinical Research Committee of the National Heart, Lung and Blood Institute. Mononuclear cells were isolated by Ficoll/Hypaque (Pharmacia) density gradient centrifugation (15) .
LGL Enrichment. Peripheral blood mononuclear cells were purified by adherence/nonadherence separation on plastic surfaces and nylon wool columns. Nonadherent cells were applied to a seven-layer discontinuous Percoll density gradient (16) . Low-density cells, which are mostly LGL, were obtained in fractions II and III. These fractions were pooled and used as the LGL-enriched population.
Immunofluorescence Staining. Cells (1-2 x 106) were incubated at room temperature with the monoclonal antibody (20 ,ul of a solution containing 50-100 ,ug of antibody per ml) for 30 min, washed once, and incubated at 4°C with an appropriate amount of affinity-purified fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG and IgM (Boerhinger Mannheim). Antibody dilutions were made in Hepesbuffered Hanks' balanced salt solution containing 2% fetal calf serum and 0.1% sodium azide, which also was used as the wash solution. The stained cells were washed once before further analysis. For experiments in which viable stained cells were-required, sodium azide was deleted from the diluent and wash solutions.
For experiments utilizing double-immunofluorescence staining, FITC-or phycoerythrin-conjugated Leu 2a, Leu 3b, and Leu 7 (purchased from Becton Dickinson FACS Systems) were used. Antibodies Leu 7, G7C8, and F7F7 were conjugated to biotin (17) and used in combination with phycoerythrin-conjugated avidin purchased from Becton Dickinson FACS Systems.
Fluorescence Analysis. Stained cells were analyzed on a fluorescence-activated cell sorter (FACS) II instrument Abbreviations: MAG, myelin-associated glycoprotein; FACS, fluorescence-activated cell sorter; LGL, large granular lymphocyte(s); FITC, fluorescein isothiocyanate. tPresent address: Barbara Davis Center for Childhood Diabetes, University of Colorado Medical Center, Box #B-140, 4200 E. Ninth Ave., Denver, CO 80262. §To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. balanced salt solution in place of the first antibody. In these plots, numbers on the x axis and y axis are arbitrary units for light scatter and fluorescence, respectively, while the contours represent cuts made at various levels through a plot of cell number on the z axis. By integrating areas under the curves, Leu 7 and G7C8 were found to stain between 10% and 15% of the peripheral blood lymphocytes. mount of an aliquot containing approximately 1 x 103 cells was prepared and stained with Giemsa solution (14) . Natural killer cell activity was assayed by the release of 51Cr from K562 target cells (18) . Fig. 1 demonstrates the fluorescence profiles obtained by FACS analysis with Leu 7 and with a monoclonal antibody produced against human MAG, G7C8. They both react with -10-15% of the peripheral blood mononuclear cell populations. Further, these cells have similar light-scattering properties. Several other monoclonal antibodies produced to human MAG (E8B8, C6D9, and F7F7) gave similar profiles by FACS analysis (not shown). All of these monoclonal antibodies raised to human MAG as well as Leu 7 have been shown to recognize determinants in the carbohydrate moieties of this glycoprotein. B11F7 and D7E10, two other monoclonal antibodies produced to human MAG but binding to polypeptide epitopes in the glycoprotein, did not react with any of the peripheral blood mononuclear cells (not shown).
RESULTS
Morphologically, the cells recognized by the monoclonal antibody G7C8 were -10-12 ,Am in diameter with large kidney-shaped nuclei (Fig. 2) . Large azurophilic granules were easily seen in the cytoplasm. Identical results were obtained with antibodies F7F7 and Leu 7. These results are consistent with the previously published morphological characteristics of the LGL recognized by Leu 7 (14) .
To further investigate the relationship between the populations recognized by the various monoclonal antibodies, cells were double-stained and analyzed with the FACS system. Generally antibodies Leu 7, G7C8, and F7F7 reacted similarly (Table 1 ). All three shared reactivity with a population of Leu 2 or cytotoxic/suppressor T cells (13-19% of the Leu 2-positive cells stained with G7C8, F7F7, or Leu 7). They also shared reactivity with a small but significant population of Leu 3 or helper/inducer T cells (4.0-6.0%). Also, when cells are double-labeled with Leu 7 and G7C8 or F7F7, approximately one-third of the Leu 7-labeled cells are labeled with G7C8 or F7F7. If these antibodies were reacting with the same cells, one might expect to see a percentage value approaching 100% (as seen in Table 1 Table 1 , although the antibodies are recognizing the same subset of -lymphocytes. Cells stained with Leu 7 or G7C8 were separated into antibody-positive and antibody-negative (unreactive) populations by using the FACS system and were assayed for natural killer cell activity. A much higher level of natural killer cell activity was found in both Leu 7 and G7C8 reactive populations compared to the unreactive cells (Table 2) .
Peripheral blood mononuclear cells were enriched for LGL by Percoll density gradient centrifugation and immunostained with Leu 7, G7C8, and F7F7. A 2-to 3-fold enrichment for antibody reactive cells over the unfractionated cells was obtained (Table 3) .
DISCUSSION
The murine monoclonal antibody Leu 7 defines a cell-surface antigen that is selectively expressed on human granular lymphocytes with natural killer (NK) and killer (K) cell function (14) . Cells recognized by this antibody also exhibit suppressor cell activity (20) . Recently Leu 7 was also shown to immunostain components of nervous tissue including myelin sheaths (6, 7) . The carbohydrate epitope recognized by Leu 7 is present in the myelin-associated glycoprotein of both the central and peripheral nervous system (7-9) and in other glycoconjugates of the peripheral nervous system (9, 10).
In the present study, we tested the reactivity to peripheral blood mononuclear cells of previously characterized monoclonal antibodies prepared from mice immunized with hu- (21) reported similarly that a rabbit polyclonal antiserum raised against human MAG bound to Leu 7-positive lymphocytes. We have shown that Leu 7 and the MAG monoclonal antibodies react with approximately the same percentage of peripheral blood mononuclear cells and that the respective populations are similar, both morphologically and with respect to natural killer cell activity. These cells also displayed a significant overlap with the cytotoxic/suppressor T cells defined by Leu 2 (Table 1 ). This conforms with the idea that natural killer cells possess suppressor cell activity (discussed above) and is consistent with the findings of Rumpold et al., (22) who found significant Leu 2 reactivity in populations of natural killer cells. Finally, enriching for LGL results in a similar percentage increase in cells reactive for each of the antibodies.
A preliminary communication (23) suggesting that the HNK-1-associated antigen on lymphocytes is a protein of Mr -100,000 makes it tempting to postulate that MAG itself is present on LGL. However, our finding that monoclonal antibodies reacting with polypeptide determinants in MAG do not react with these cells suggests caution in making such an extrapolation. Since all of the monoclonal antibodies identifying this subset of lymphocytes react with antigens in the carbohydrate moieties of MAG and other glycoconjugates, the lymphocyte antigen may be a different glycoprotein containing a carbohydrate epitope also present in MAG.
In any case, our results provide further evidence for shared antigenic determinants between the nervous and immune systems. Since loss of MAG appears to be an early event in the development of some multiple sclerosis plaques (24) (25) (26) (27) and MAG determinants are present on lymphocytes with natural killer and T suppressor cell function, this finding may have implications for the pathogenesis of this disease. A similar suggestion by Oger et al. (5) was based on oligodendrocytes and T suppressor lymphocytes sharing the (28, 29) , it is clear from the results described here than an antigenic determinant in MAG is shared with natural killer and some T suppressor cells. Therefore, an immune reaction against this shared antigen could contribute to the decrease in T suppressor cells as well as the decreased natural killer cell activity (30) (31) (32) (33) that have been reported in multiple sclerosis. Since natural killer and T suppressor cells are important in immune regulation, a further imbalance in the immune system could result. A similar situation has been described for myasthenia gravis in which acetylcholine receptor-like antigens have been found in the human thymus and on lymphocytes (3, 4) .
These findings may also be relevant to demyelinating peripheral neuropathy associated with plasma cell dyscrasia. IgM paraproteins reacting with MAG have been described in some patients with this disease (19, (34) (35) (36) . Similar to HNK-1 and the murine monoclonal antibodies to MAG (G7C8 and F7F7), the IgM monoclonal antibodies in these patients react with a carbohydrate epitope that is in MAG and some lower molecular weight glycoproteins and a glycolipid of human peripheral nerve (refs. 9, 10, 19, and 37; unpublished results). This and other evidence suggests that the paraproteins and the mouse monoclonal antibodies described in this paper are reacting with the same or very similar epitopes. Murray and Steck have put forth a hypothesis relating the occurrence of this antigen on lymphocytes to the etiology of this type of neuropathy (38) . Consistent with this idea is the finding of a pronounced decrease in the number of circulating Leu 7-positive cells in individuals with this disease, although this was not observed in another investigation (39) . It has not been established how the IgM paraproteins relate to the pathology in this type of neuropathy (40) , and further research is required to define the role of this shared antigen in autoimmune demyelinating diseases.
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